Table 2.
Subject characteristics.
| Subject | Group | Gender | Age (year) | Weight (kg) | Height (m) | Lesion level | AIS level | Etiology | Lesion time (months) |
|---|---|---|---|---|---|---|---|---|---|
| SHL | – | F | 32 | 58 | 1.79 | – | – | – | – |
| S1A | I | F | 35 | 48 | 1.65 | T12 | C | Trauma | 33 |
| S1B | I | M | 33 | 90 | 1.85 | L1 | D | Trauma | 18 |
| S2A | II | M | 52 | 82 | 1.78 | T7 | A | Trauma | 13 |
| S2B | II | M | 25 | 64 | 1.85 | T11-T12 | A | Trauma | 71 |
| S2C | II | M | 28 | 70 | 1.82 | T9 | A | Trauma | 49 |
| S2D | II | M | 24 | 63 | 1.80 | T7 | A | Trauma | 61 |
SHL is a healthy subject, S1A and S2A are Group I subjects (incomplete injury), and S2A, S2B, S2C, and S2D are Group II subjects (complete injury). Lesion and AIS level from clinical neurological assessment, lesion time is the time from lesion diagnosis to data measurement (in months).